Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abbott Laboratories (ABT) vs Build A Bear Workshop Inc (BBW) Price & Performance

Abbott Laboratories
Build A Bear Workshop Inc

Price performance

Price movement over the last 24 hours

Key statistics

Abbott Laboratories vs Build A Bear Workshop Inc — how do they compare? Abbott Laboratories trades at $95.51 (market cap $166.94B), while Build A Bear Workshop Inc trades at $30.09 (market cap $388.91M). The key difference: Abbott Laboratories is far larger — about 429.3× Build A Bear Workshop Inc's market cap, and Build A Bear Workshop Inc pays the higher dividend (2.97%). Which is the better fit depends on your goals.

ABTBBW
Market Cap
$166.94B$388.91M
Sector
HealthConsumer Cyclical
52-Week High
$136.62$75.85
52-Week Low
$82.57$29.84
Enterprise Value
$193.69B$488.35M
Dividend Yield
2.63%2.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abbott Laboratories

Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.

The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.

Build A Bear Workshop Inc

Build-A-Bear Workshop (BBW) trades at $31.02, down 1.52% on the day, with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics, including a P/E of 7.26 and a P/S of 0.76, alongside strong profitability with a net income margin of 10.48%. Recent developments include a CEO transition to Chris Hurt and the declaration of a $0.23 quarterly dividend payable in July 2026.

The long-term outlook is supported by a debt-free balance sheet, international expansion, and a 72.73% analyst buy rating with a $62.50 consensus price target, implying significant upside. Near-term risks include consumer spending pressures and revenue guidance reductions, but the fundamental setup remains attractive for recovery in the latter half of the year.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Read more on ABT

About Build A Bear Workshop Inc

Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.

Read more on BBW